The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
about
Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulationMiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor MetabolismMicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1miR-125b is associated with renal cell carcinoma cell migration, invasion and apoptosis.Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluationmiR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics.MicroRNA-30e targets BNIP3L to protect against aldosterone-induced podocyte apoptosis and mitochondrial dysfunction.MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.Noncoding RNAs in Growth and Death of Cancer Cells.Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy.MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma.MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway.MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy.
P2860
Q28066991-84C130A7-7243-4392-A549-8D147E3AD9C0Q28551765-D74646C2-21AB-4F8E-80E6-85DE2993CCD1Q28554012-B5298D15-95CD-4434-BC1C-E3109E54E27DQ33751241-6BFF01B7-BB44-460D-920D-19BB3FE6FE89Q35993546-C183093F-5D58-4BAA-BFC5-52D06F672DA2Q36908874-7E1AABE9-8323-41E9-93CA-AEA3933209D1Q37150075-E9D41A4F-6B2A-4B16-A68F-BCF78004C20BQ37679172-6E9D6238-5A62-4F51-A6F3-EB96189E0A71Q38726222-6D77136B-8783-4B36-94B8-B0A5F6AD5C17Q38817543-231A9D4B-80B7-48EA-A020-D0FD7FFD5F9FQ38819255-D8E964D9-99C7-4153-B29C-80934E41BC8EQ38845436-FACC7B82-8C45-4B65-BC1B-9A9D04B65AFAQ38848505-FAA011A7-EFD1-42B1-8B41-0D833CBA6435Q41215178-D89177E5-D1AA-4062-89CA-D92A1B8A2EC3Q47098435-E949A83A-CF4B-45D5-A213-25C8D98C691FQ55244594-ABA9A95E-DFC6-4991-9FE3-DFCEF765641F
P2860
The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@en
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@nl
type
label
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@en
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@nl
prefLabel
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@en
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@nl
P2093
P2860
P1433
P1476
The role of miR-125b-mitochond ...... herapy in human breast cancer.
@en
P2093
Shuo Zhang
Xiaohong Xie
Yongqing Fu
Yuanyuan Hu
P2860
P2888
P304
P356
10.1007/S13277-015-3438-7
P577
2015-04-17T00:00:00Z